For the year ended March 31, 2025, McKesson said revenues increased 16%, gross profit increased 4%, and total operating expenses were flat compared to the prior year. Diluted earnings per common share from continuing operations attributable to McKesson increased to $25.72 from $22.39 in the prior year.

1. 01

   For the year ended March 31, 2025, McKesson said revenues increased 16%, gross profit increased 4%, and total operating expenses were flat compared to the prior year. Diluted earnings per common share from continuing operations attributable to McKesson increased to $25.72 from $22.39 in the prior year.

2. 02

   The company completed the sale of its Canadian retail disposal group on December 30, 2024 for an adjusted purchase price consisting of a cash payment of $9 million and a note of $120 million payable at the end of 6 years. It recorded a charge of $667 million in total operating expenses to remeasure the Canadian retail disposal group to fair value less costs to sell, of which $48 million was a loss related to accumulated other comprehensive loss balances associated with the disposal group.

3. 03

   McKesson recorded restructuring, impairment, and related charges of $286 million in fiscal 2025 and $115 million in fiscal 2024. The company's selling, distribution, general, and administrative expenses in fiscal 2025 included a credit of $206 million related to the bankruptcy of Rite Aid, while fiscal 2024 included a provision for bad debts of $725 million related to the same bankruptcy.

4. 04

   On August 26, 2024, McKesson entered into a definitive agreement to acquire a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC for approximately $2.49 billion in cash, subject to customary adjustments, and said it expects the transaction to close during Q1 of fiscal 2026. The company also said it completed the acquisition of an approximate 80% controlling interest in PRISM Vision Holdings, LLC on April 2, 2025.

Key figures

Fiscal year ended March 31, 2025

Revenue

$359.1B

Operating income

$4.4B

Net income

$3.3B

EPS

$25.72

Gross profit

$13.3B

Operating cash flow

$6.1B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.